Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
The Digital Chamber filed a lawsuit against Illinois over a 0.2% tax on digital asset transactions, arguing the levy ...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
A Sydney-based tech founder uses AI to design a bespoke cancer vaccine for his dog, Rosie, signaling a new frontier i...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
The launch of groundbreaking prediction market ETFs is delayed again as the SEC broadens its review. Analysts say the...
Microsoft is weighing a billion-dollar investment in OpenAI, with talks centering on a possible up-to-10-billion plan...
As of mid-May 2026, two retail ETFs diverge sharply: RTH climbs on mega-cap strength, while XRT drifts lower with a b...
Nvidia has surged on AI-driven demand, but June could bring new momentum—or volatility. This article breaks down the ...
The Hormuz crisis is now a farm and food story. The ICC warns that fertilizer shipments could stall, triggering harve...
Crypto traders reacted to reports that Sam Bankman-Fried is seeking a presidential pardon, sending the FTT token shar...